¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Immune Oncology Forum 2019_From the basics for CRA/CRC & Young investigators : 2019-07-12

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ´ëÇÑÁ¾¾ç³»°úÇÐȸ KSMO Immune Oncology Forum 2019_From the basics for CRA/CRC & Young investigators : 2019-07-12
±³À°ÀÏÀÚ : 2019-07-12
±³À°Àå¼Ò : ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F)  
±³À°ÁÖÁ¦ : KSMO Immune Oncology Forum 2019_From the basics for CRA/CRC & Young investigators
ÁÖÃÖ±â°ü : ´ëÇÑÁ¾¾ç³»°úÇÐȸ(17.5 ¸íĪº¯°æ Çѱ¹ÀÓ»ó¾ÏÇÐȸ)
´ã´çÀÚ : Á¶¼ºº¹
¿¬¶ôó : 02-735-2857  
À̸ÞÀÏ : ksmo@ksmo.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 100¸í
Èñ¸ÁÆòÁ¡ : 3Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 3 ½Ã°£ 40ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í È¸¿ø : ¹«·á (»çÀüµî·Ï, ÇöÀåµî·Ï) ºñȸ¿ø - »çÀüµî·Ï CRC 10,000 / CRA 20,000 / ±âŸ 30,000 ºñȸ¿ø - ÇöÀåµî·Ï CRC 20,000 / CRA 30,000 ±âŸ 40,000      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 14:00~14:25 Immune Checkpoint Regulation in Cancer  À±½Å±³(¼­¿ï¾Æ»êº´¿ø) 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 14:25~14:50 Immune Checkpoint Inhibitors in Cancer: Biomarker/Cancer type-based Approvals  °­ÀºÁÖ(°í´ë±¸·Îº´¿ø) 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 14:50~15:15 Combination stragtegies of Immune Checkpoint Inhibitors in Cancer: Failure and Success  ¹Ú±Ç¿À(¾ç»êºÎ»ê´ëÇб³º´¿ø) 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 15:15~15:40 Predictive biomarkers beyond PD-L1 expression and Tumor Mutational Burden  ¿ÁÂù¿µ(¼­¿ï´ëÇб³º´¿ø) 
È޽Ġ07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 15:40~16:00 Coffee Break  () 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 16:00~16:25 iRECIST and Endpoints in Immune Checkpoint Inhibitors  À̼öÁ¤(°æºÏ´ëÇб³º´¿ø) 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 16:25~16:50 Immune-related Adverse Events and Managements  Á¶»óÈñ(È­¼øÀü³²´ëÇб³º´¿ø) 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 16:50~17:15 Translational Research in Immune Checkpoint Inhibitors  Á¤Çö¾Ö(ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø) 
±³À°½Ã°£ 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 17:15~17:40 New Emerging Immune Checkpoint Inhibitors in Cancer  È«¹ÎÈñ(¿¬¼¼¾Ïº´¿ø) 
Åä·Ð 07-12 ¼­¿ï´ëÇб³ ¾î¸°À̺´¿ø ÀÓ»óÁ¦1°­ÀÇ½Ç (1F) 17:40~18:00 Q&A  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ÀüºÏ´ëÇб³º´¿ø ´ëÇÑÀÎÅͺ¥¼Ç¿µ»óÀÇÇÐȸ 2019³â »ï³²Áöȸ ½ÉÆ÷Áö¾ö : 2019-07-13
´ÙÀ½±Û ¼­¿ï´ëÇб³º´¿ø ´ëÇѳú½Å°æÀçÈ°ÇÐȸ Á¦36Â÷ ÇмúÁý´ãȸ : 2019-07-11
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20790 °æ±â ´ëÇÑÇǺΰúÇÐȸ Á¦52Â÷ ÀÎõºÎõÁöºÎȸ ÇмúÁý´ãȸ : 2024-06-15 0 3 2024-05-27
20789 ¼­¿ï 2024³â ´ëÇѽŰæ±ÙÀ°ÁúȯÇÐȸ ¿¬¼ö°­Á : 2024-06-15 0 6 2024-05-27
20788 Á¦ÁÖ ´ëÇѳ»ºÐºñÇÐȸ Á¦22ȸ ºÐ°úÀü¹®ÀÇ ¿¬¼ö°­Á : 2024-06-15 0 4 2024-05-27
20787 Ãæ³² (¿Â¶óÀÎ)2024³âµµ Ãæû³²µµÀÇ»çȸ Ãá°èÇмú´ëȸ : 2024-06-15 0 6 2024-05-27
20786 ºÎ»ê KSMO ºÎ»ê¿ï»ê°æ³²/´ë±¸°æºÏÁöȸ °øµ¿ ½ÉÆ÷Áö¾ö : 2024-06-14 0 4 2024-05-27
20785 ¼­¿ï 2024³â ´ëÇѺҾÈÀÇÇÐȸ Ãá°èÇмú´ëȸ (´Ù½Ã, °Ü¿ï³ª¹«¿¡¼­ º½ ³ª¹«¿¡·Î From Traditional approaches to Innovation in Psychiatry) : 2024-06-14 0 7 2024-05-27
20784 ¼­¿ï ´ëÇÑ°áÇÙÇùȸ 2024³â °áÇÙ°ü¸®±³À° 1±â(2ÀÏÂ÷) : 2024-06-14 0 4 2024-05-27
20783 ¼­¿ï Á¦14Â÷ Çѱ¹ÃÖ¼Òħ½ÀÃéÀå¼ö¼ú¿¬±¸È¸ : 2024-06-14 0 3 2024-05-27
20782 ´ëÀü 2024 Á¦40ȸ ´ëÇѼҾƿܰúÇÐȸ Ãá°èÇмú´ëȸ ¹× 40Áֳ⠱â³äÇà»ç (2ÀÏÂ÷) : 2024-06-14 0 5 2024-05-27
20781 ´ë±¸ Ä¥°î°æºÏ´ëÇб³º´¿ø RARE DISEASE SYMPOSIUM 2024 : 2024-06-14 0 2 2024-05-27
20780 ºÎ»ê 2024 ´ëÇѽŰæ¿Ü°úÇÐȸ ºÎ»ê¿ï»ê°æ³²Áöȸ Á¦2Â÷ Á¤±âÇмú´ëȸ : 2024-06-14 0 7 2024-05-27
20779 ¼­¿ï 2024 ´ëÇÑÀÇÇÐȸ Çмú´ëȸ : 2024-06-14 0 5 2024-05-27
20778 ¼­¿ï ´ëÇÑÁø´ÜÀ¯ÀüÇÐȸ 2024³â Á¦19Â÷ Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20777 ¼­¿ï 2024 ´ëÇÑÈ­»óÇÐȸ Çмú´ëȸ(2ÀÏÂ÷) : 2024-06-14 0 7 2024-05-27
20776 ºÎ»ê 2024³â Çѱ¹°£´ãÃé¿Ü°úÇÐȸ ºÎ¿ï°æÁöȸ °£ÀÌ½Ä ½ÉÆ÷Áö¾ö : 2024-06-14 0 5 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷